{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:05:18Z","timestamp":1783101918491,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A worldwide increased incidence of HM has been marked in recent decades. Therefore, to update epidemiological characteristics of HM in a French West Indies territory, we have performed analysis through Martinique's population-based cancer registry database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included cancer case data, from 2009\u20132018, coded in strict compliance with international standards set by International Agency for Research on Cancer. We calculated standardized incidence rates, cumulative rate (ages 0\u201374), and temporal trends for cases and deaths using the global population standard, by sex and five age group. Mortality rates were obtained from the French Epidemiology Center on Medical Causes of Death (C\u00e9piDc).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One thousand forty seven new cases and 674 deaths from HM were recorded, of which 501 MM (47.8%), 377 LMNH (36%), 123 LAM (11.8%), and 46 LH (4.4%) were reported in both sexes. MM is one of the hematological malignancies with the highest incidence in Martinique among men. Temporal trends of incidence rates for all HM decreased overall in both sexes, except for MM in men. There is significant variability in mortality rates for both sexes. In addition, over the period, the temporal trends of mortality rates for all HMs has decreased overall. Gender-specific rates, between 2009 and 2018, showed that all lymphoid HM have a multimodal distribution curve that increased with age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Characteristics of HM in Martinique over the reporting periods differ from mainland France. Higher incidences have been observed, particularly for MM, and non-significant sub-mortality is observed compared to mainland France. Moreover, temporal distribution of mortality and incidence trends had decreased over the reporting periods except for MM. Our results showed similarities with African-Americans groups in United States and in particular an equivalence in the frequency distribution of diagnosed HM. However, SMR remains lower compared to US black ethnic groups. Our results contributed to expanding knowledge on the epidemiology of HM with Caribbean data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-023-11666-9","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T10:03:04Z","timestamp":1701856984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A population-based analysis of hematological malignancies from a French-West-Indies cancer registry\u2019s data (2009\u20132018)"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-4135","authenticated-orcid":false,"given":"R\u00e9mi","family":"Houpert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Almont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostom","family":"Belahreche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadi","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Okouango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Vestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Macni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Pierre-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Montabord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Beaubrun-Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naby","family":"Soumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"V\u00e9ronique-Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Joachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"issue":"4","key":"11666_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/hon.660","volume":"19","author":"JK Chan","year":"2001","unstructured":"Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol Oncol. 2001;19(4):129\u201350.","journal-title":"Hematol Oncol"},{"key":"11666_CR2","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman J, editors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer Press; 2001."},{"issue":"1","key":"11666_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4143\/crt.2017.093","volume":"50","author":"H Lee","year":"2018","unstructured":"Lee H, Park HJ, Park EH, Ju HY, Oh CM, Kong HJ, et al. Nationwide statistical analysis of lymphoid malignancies in Korea. Cancer Res Treat. 2018;50(1):222\u201338.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"11666_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-019-0785-7","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W, Liu J, Song Y, Zeng X, Wang X, Mi L, et al. Burden of lymphoma in China, 2006\u20132016: an analysis of the global burden of disease study 2016. J Hematol Oncol. 2019;12(1):115.","journal-title":"J Hematol Oncol"},{"issue":"25","key":"11666_CR5","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","volume":"116","author":"AJ Waxman","year":"2010","unstructured":"Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116(25):5501\u20136.","journal-title":"Blood"},{"issue":"6","key":"11666_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1055-9965.EPI-11-0038","volume":"20","author":"CA Clarke","year":"2011","unstructured":"Clarke CA, Glaser SL, Gomez SL, Wang SS, Keegan TH, Yang J, et al. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1064\u201377.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"11666_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2014-10-609461","volume":"125","author":"PS Rosenberg","year":"2015","unstructured":"Rosenberg PS, Barker KA, Anderson WF. Future distribution of multiple myeloma in the United States by sex, age, and race\/ethnicity. Blood. 2015;125(2):410\u20132.","journal-title":"Blood"},{"issue":"6","key":"11666_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1182\/blood-2013-03-491514","volume":"122","author":"D Tan","year":"2013","unstructured":"Tan D, Horning SJ, Hoppe RT, Levy R, Rosenberg SA, Sigal BM, et al. Improvements in observed and relative survival in follicular grade 1\u20132 lymphoma during 4 decades: the Stanford University experience. Blood. 2013;122(6):981\u20137.","journal-title":"Blood"},{"key":"11666_CR9","volume-title":"Estimations r\u00e9gionales et d\u00e9partementales d\u2019incidence et de mortalit\u00e9 par cancers en France, 2007-2016","author":"C Joachim-Contaret","year":"2019","unstructured":"Joachim-Contaret C, Veronique-Baudin J, Macni J, Ulric-Gervaise S, Cariou M, Billot-Grasset A, et al. Estimations r\u00e9gionales et d\u00e9partementales d\u2019incidence et de mortalit\u00e9 par cancers en France, 2007-2016. 2019."},{"issue":"6","key":"11666_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"11666_CR11","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"11666_CR12","unstructured":"Boyle P, Parkin DM. Chapter 11. Statistical methods for registries. Cancer Registration: Principles and Methods. 95. Lyon: IARC Scientific Publication; 1991."},{"issue":"3","key":"11666_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","volume":"56","author":"A Belot","year":"2008","unstructured":"Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, et al. Cancer incidence and mortality in France over the period 1980\u20132005. Rev Epidemiol Sante Publique. 2008;56(3):159\u201375.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"3","key":"11666_CR14","first-page":"166","volume":"7","author":"J Orem","year":"2007","unstructured":"Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007;7(3):166\u201375.","journal-title":"Afr Health Sci"},{"key":"11666_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.","journal-title":"Front Microbiol"},{"issue":"5","key":"11666_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/sj.leu.2402040","volume":"15","author":"C Besson","year":"2001","unstructured":"Besson C, Gonin C, Brebion A, Delaunay C, Panelatti G, Plumelle Y. Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia\/lymphoma. Leukemia. 2001;15(5):828\u201331.","journal-title":"Leukemia."},{"key":"11666_CR17","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.canep.2020.101709","volume":"66","author":"PS Pinheiro","year":"2020","unstructured":"Pinheiro PS, Medina H, Callahan KE, Kwon D, Ragin C, Sherman R, et al. Cancer mortality among US blacks: Variability between African Americans, Afro-Caribbeans, and Africans. Cancer Epidemiol. 2020;66:101709.","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"11666_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10552-008-9184-z","volume":"19","author":"JD Carreon","year":"2008","unstructured":"Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, et al. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996\u20132004. Cancer Causes Control. 2008;19(10):1171\u201381.","journal-title":"Cancer Causes Control"},{"key":"11666_CR19","volume-title":"Cancer Incidence in Five Continents Volume X: IARC Scientific Publication No. 164","author":"DBF Forman","year":"2014","unstructured":"Forman DBF, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer Incidence in Five Continents Volume X: IARC Scientific Publication No. 164. 2014."},{"key":"11666_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"V de TietscheMoraes Hungria","year":"2019","unstructured":"de TietscheMoraes Hungria V, Chiattone C, Pavlovsky M, Abenoza LM, Agreda GP, Armenta J, et al. Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology Latin America observational registry study. J Glob Oncol. 2019;5:1\u201319.","journal-title":"J Glob Oncol"},{"issue":"19","key":"11666_CR21","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1182\/blood-2009-03-209601","volume":"114","author":"W Cozen","year":"2009","unstructured":"Cozen W, Hamilton AS, Zhao P, Salam MT, Deapen DM, Nathwani BN, et al. A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma. Blood. 2009;114(19):4014\u201320.","journal-title":"Blood"},{"issue":"1","key":"11666_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2141.2009.07721.x","volume":"146","author":"LR Goldin","year":"2009","unstructured":"Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91\u20134.","journal-title":"Br J Haematol"},{"issue":"10","key":"11666_CR23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3324\/haematol.2009.010512","volume":"94","author":"SY Kristinsson","year":"2009","unstructured":"Kristinsson SY, Landgren O, Sjoberg J, Turesson I, Bjorkholm M, Goldin LR. Autoimmunity and risk for Hodgkin\u2019s lymphoma by subtype. Haematologica. 2009;94(10):1468\u20139.","journal-title":"Haematologica"},{"key":"11666_CR24","unstructured":"Guyader-Peyrou SL, Defossez G, Dantony E, Mounier M, Cornet E, Uhry Z, et al. Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. Volume 2 - H\u00e9mopathies malignes. 2019."},{"key":"11666_CR25","unstructured":"Noone AM HN, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975\u20132015, National Cancer Institute. Bethesda, MD, based on November 2017 SEER data submission, posted to the SEER web site, April 2018. 2018 [Available from: https:\/\/seer.cancer.gov\/csr\/1975_2015\/."},{"issue":"Suppl 12","key":"11666_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.22719","volume":"120","author":"DD Alexander","year":"2007","unstructured":"Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl 12):1\u201339.","journal-title":"Int J Cancer"},{"issue":"3","key":"11666_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/02841860500531682","volume":"45","author":"K Ekstrom-Smedby","year":"2006","unstructured":"Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma\u2013a review. Acta Oncol. 2006;45(3):258\u201371.","journal-title":"Acta Oncol"},{"issue":"48","key":"11666_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","volume":"2014","author":"LM Morton","year":"2014","unstructured":"Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014(48):130\u201344.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"48","key":"11666_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jncimonographs\/lgu005","volume":"2014","author":"LM Morton","year":"2014","unstructured":"Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, et al. Rationale and design of the international lymphoma epidemiology consortium (InterLymph) non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014(48):1\u201314.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"11666_CR30","unstructured":"IARC. IARC Monographs on the identification of carcinogenic hazards to humans 2022 [updated 2022\u201309\u201307 10.34am (CEST). Agents classified by the IARC Monographs, Volumes 1\u2013132]. Available from: http:\/\/monographs.iarc.fr\/ENG\/Classification\/latest_classif.php."},{"key":"11666_CR31","first-page":"27","volume-title":"\u00c9tude de la r\u00e9partition spatiale des cancers possiblement li\u00e9s \u00e0 la pollution des sols par les pesticides organochlor\u00e9s, en Martinique","author":"A Dieye","year":"2019","unstructured":"Dieye A, Qu\u00e9nel P, Goria S, Blateau A, Colonna M, Azaloux H. \u00c9tude de la r\u00e9partition spatiale des cancers possiblement li\u00e9s \u00e0 la pollution des sols par les pesticides organochlor\u00e9s, en Martinique. Saint-Maurice: Institut de veille sanitaire, ao\u00fbt; 2019. p. 27."},{"key":"11666_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387.","journal-title":"Eur J Cancer"},{"issue":"1","key":"11666_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/14653240802666050","volume":"11","author":"J Jansen","year":"2009","unstructured":"Jansen J, Nolan PL, Reeves MI, Akard LP, Thompson JM, Dugan MJ, et al. Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration. Cytotherapy. 2009;11(1):79\u201385.","journal-title":"Cytotherapy"},{"issue":"9","key":"11666_CR34","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/bmt.2013.51","volume":"48","author":"JR Passweg","year":"2013","unstructured":"Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant. 2013;48(9):1161\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"11666_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ejh.12362","volume":"94","author":"K Hubel","year":"2015","unstructured":"Hubel K, de la Rubia J, Azar N, Corradini P. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol. 2015;94(1):12\u201322.","journal-title":"Eur J Haematol"},{"key":"11666_CR36","unstructured":"ANSM: Agence nationale des produits de sant\u00e9. \"Rapport d\u2019activit\u00e9 biovigilance 2011\". 2012;31\u201332."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11666-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T10:04:19Z","timestamp":1701857059000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11666-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11666"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11666-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2977867\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The cancer registry of Martinique is authorized by the French Data Protection Authority, Commission National Informatique et Libert\u00e9 (CNIL), authorization N\u00b0 987001 of november 16, 1987. (Date of last CNIL amendment: June 05, 2015) Given their public health mandate, French cancer registries are authorized by the French Data Protection Authority \u201cCommission National Informatique et Libert\u00e9\u201d (CNIL), to collect data on cancer cases with a waiver for written informed consent (CNIL deliberation n\u00b003\u2013053 of November 27, 2003). Patients\u2019 information is given by notices displayed in health care facilities, their attending physician or specialist. General information is also available on the National Cancer Institute website:\n                      \n                      . This study obtained ethics approval from the research ethic committee of the Comit\u00e9 de Protection des Personnes Ile de France IV Institutional Review Board Agreement of US Department of Health and Human Services, N\u00b0IRB 00003835. The Privacy Impact Assessment (PIA) was votted by the data protection ofcer of the University Hospital of Martinique (dpo@chu-martinique.fr) in accordance to the General Data Protection Regulation (GDPR). The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Consent for publication was not required since our project do not involve patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1197"}}